1. Antivascular Therapy for Orthotopic Human Ovarian Carcinoma through Blockade of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptors
    Premal H. Thaker et al, 2005, Clinical Cancer Research CrossRef
  2. The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma
    Jonathan A. Hickson et al, 2006, Cancer Research CrossRef
  3. Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor β Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model
    Lei Xu et al, 2005, Cancer Research CrossRef
  4. The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors
    Justyna Mikuła-Pietrasik et al, 2017, BioMed Research International CrossRef
  5. Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical Model
    Rakesh K. Jain et al, 2007, Cancer Research CrossRef
  6. Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer
    Ena Wang et al, 2005, Clinical Cancer Research CrossRef
  7. Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
    Luigi Manenti et al, 2005, Molecular Cancer Therapeutics CrossRef
  8. Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma
    Chunhua Lu et al, 2007, Clinical Cancer Research CrossRef
  9. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells
    Luai Al-Marzouki et al, 2023, Gastric Cancer CrossRef
  10. miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition
    Siti A. Sulaiman et al, 2016, Frontiers in Pharmacology CrossRef
  11. Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
    Stefanie Avril et al, 2017, Oncotarget CrossRef
  12. Angiogenesis and Lung Cancer: Prognostic and Therapeutic Implications
    Roy S. Herbst et al, 2005, Journal of Clinical Oncology CrossRef
  13. 2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations
    Evgenia Halkia et al, 2018, Gastroenterology Research and Practice CrossRef
  14. Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice
    Dina Chelouche Lev et al, 2005, Clinical Cancer Research CrossRef
  15. Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine
    Monique B. Nilsson et al, 2005, Cancer Research CrossRef